"Survodutide (BI 456906): A Novel Dual GLP-1/Glucagon Receptor Agonist." Diabetes 71.Supplement_1 (2022)
Semaglutide, marketed under brand names including Ozempic, Wegovy, and Rybelsus, is a glucagon-like peptide-1 (GLP-1) receptor agonist approved for type 2 diabetes management and chronic weight management
Autosomal recessive forms are associated with mutations of parkin:PARK2 and PTEN-induced putative kinase 1 (PINK1:PARK6) gene loci
Under in vitro conditions, disruption of Syns tertiary ensemblesthrough charge neutralization (acidic pH or Ca 2+ addition), C-terminal truncation, or Syn-S129p could expose the hydrophobic (NAC) region and transform it into a metastable, reactive state 15,68
Mitochondrial nitric-oxide synthase stimulation causes cytochrome c release from isolated mitochondria: evidence for intramitochondrial peroxynitrite formation